BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 59 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2022. The put-call ratio across all filers is 2.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $34,381 | +5.0% | 18,191 | 0.0% | 0.00% | – |
| Q4 2022 | $32,744 | +5.6% | 18,191 | -0.4% | 0.00% | – |
| Q3 2022 | $31,000 | -31.1% | 18,265 | 0.0% | 0.00% | – |
| Q2 2022 | $45,000 | -81.5% | 18,265 | -79.1% | 0.00% | – |
| Q1 2022 | $243,000 | -49.1% | 87,558 | -2.2% | 0.00% | – |
| Q4 2021 | $477,000 | -43.3% | 89,551 | -9.9% | 0.00% | – |
| Q3 2021 | $841,000 | -15.3% | 99,384 | +22.0% | 0.00% | – |
| Q2 2021 | $993,000 | -33.4% | 81,495 | +32.6% | 0.00% | – |
| Q1 2021 | $1,491,000 | -26.8% | 61,474 | -3.2% | 0.00% | – |
| Q4 2020 | $2,036,000 | +14.9% | 63,539 | +8.4% | 0.00% | – |
| Q3 2020 | $1,772,000 | -9.6% | 58,605 | +26.0% | 0.00% | -100.0% |
| Q2 2020 | $1,961,000 | +158.0% | 46,529 | +52.8% | 0.00% | – |
| Q1 2020 | $760,000 | – | 30,447 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $86,074,000 | 4.50% |
| Boxer Capital, LLC | 2,014,858 | $50,271,000 | 3.43% |
| RA Capital Management | 2,589,904 | $64,618,000 | 2.04% |
| Artal Group S.A. | 1,696,517 | $42,328,000 | 1.79% |
| Logos Global Management LP | 123,465 | $2,772,000 | 1.05% |
| BVF INC/IL | 378,788 | $9,451,000 | 0.88% |
| Casdin Capital, LLC | 289,395 | $7,220,000 | 0.77% |
| Perceptive Advisors | 1,104,656 | $27,561,000 | 0.72% |
| Bellevue Group AG | 1,330,000 | $33,184,000 | 0.64% |
| Vivo Capital, LLC | 252,119 | $6,290,000 | 0.57% |